Add like
Add dislike
Add to saved papers

MR diffusion kurtosis imaging predicts malignant potential and the histological type of meningioma.

PURPOSE: To explore the value of Diffusion kurtosis imaging (DKI) metrics in the differential diagnosis of meningioma.

METHODS: For this study, we retrospectively enrolled 35 patients of cerebral meningioma with DKI which included axial diffusion coefficient (AD), radial diffusion coefficient (RD), mean diffusion coefficient (MD), fractional anisotropy (FA), axial kurtosis (AK), radial kurtosis (RK) and mean kurtosis (MK). All of these metrics were normalized according to contralateral normal-appearing white matter (NAWMc). Patients were divided into two groups (benign and malignant meningioma) and were further analyzed using the independent sample t-test and receiver operating characteristic (ROC) curve. A one-way ANOVA analysis was used to analyze four groups divided according to pathological subtypes.

RESULTS: The metrics of AD, normalized AD, normalized MD, MK and normalized MK showed a significant difference between benign and malignant group, and MK showed relatively higher diagnostic ability with its cut-off value, area under the curve (AUC), sensitivity and specificity of 0.875, 0.780, 70% and 89%, respectively. The metrics of normalized MD, RD and normalized RD, FA and normalized FA, AK and normalized AK, and RK showed significant difference among four subtypes. MK and RK in meningioma were found to correlate positively with the Ki-67 labeling index (Ki-67 LI).

CONCLUSIONS: DKI metrics may be used to differentiate benign from malignant meningioma, and also to distinguish some histological subtypes of meningioma. Moreover, DKI metrics may potentially reflect cellular proliferation.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app